BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32487886)

  • 21. Ring pessary for all pelvic organ prolapse.
    Manchana T
    Arch Gynecol Obstet; 2011 Aug; 284(2):391-5. PubMed ID: 20848116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Use of a Vaginal Pessary to Decide Whether a Mid Urethral Sling should be Added to Prolapse Surgery.
    Goessens E; Deriemaeker H; Cammu H
    J Urol; 2020 Mar; 203(3):598-603. PubMed ID: 31584852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
    Manonai J; Sarit-Apirak S; Udomsubpayakul U
    Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
    Deng M; Ding J; Ai F; Zhu L
    Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative interventions in pelvic organ prolapse surgery.
    Haya N; Feiner B; Baessler K; Christmann-Schmid C; Maher C
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013105. PubMed ID: 30121957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users.
    Mendes LC; Bezerra LRPS; Bilhar APM; Neto JAV; Vasconcelos CTM; Saboia DM; Karbage SAL
    Int Urogynecol J; 2021 Apr; 32(4):1023-1029. PubMed ID: 33048180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term adherence to pessary use in women with pelvic organ prolapse: A retrospective cohort study.
    Koch M; Carlin G; Lange S; Umek W; Krall C; Bodner-Adler B
    Maturitas; 2023 Dec; 178():107828. PubMed ID: 37659128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolapse surgery versus vaginal pessary in women with symptomatic pelvic organ prolapse: which factors influence the choice of treatment?
    Bodner-Adler B; Bodner K; Stinglmeier A; Kimberger O; Halpern K; Koelbl H; Umek W
    Arch Gynecol Obstet; 2019 Mar; 299(3):773-777. PubMed ID: 30656443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of Life after Treatment for Pelvic Organ Prolapse in Real-World Study: Recommendations, Vaginal Pessary, and Surgery.
    Mančinskienė D; Mikėnaitė M; Barakat M; Kačerauskienė J; Railaitė DR; Maleckienė L; Bartusevičius A; Bartusevičienė E
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674193
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors associated with unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: Systematic review and metanalysis.
    de Albuquerque Coelho SC; Brito LGO; de Araujo CC; Juliato CRT
    Neurourol Urodyn; 2020 Sep; 39(7):1912-1921. PubMed ID: 32649024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
    Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
    Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
    [No Abstract]   [Full Text] [Related]  

  • 32. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
    Ding J; Song XC; Deng M; Zhu L
    Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How often should ring pessaries be removed or changed in women with advanced POP? A prospective observational study.
    Miceli A; Fernández-Sánchez M; Dueñas-Díez JL
    Int Urogynecol J; 2021 Jun; 32(6):1471-1478. PubMed ID: 33620536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
    Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
    J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Affecting Successfulness of Vaginal Pessary Use for the Treatment of Pelvic Organ Prolapse.
    Lekskulchai O; Wanichsetakul P
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S115-20. PubMed ID: 26387398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study.
    van der Vaart LR; Vollebregt A; Milani AL; Lagro-Janssen AL; Duijnhoven RG; Roovers JP; Van der Vaart CH
    BJOG; 2022 Apr; 129(5):820-829. PubMed ID: 34559932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.
    Shayo BC; Masenga GG; Rasch V
    Int Urogynecol J; 2019 Aug; 30(8):1313-1321. PubMed ID: 30121703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pessary evaluation for genital prolapse treatment: From acceptance to successful fitting.
    Vasconcelos CTM; Gomes MLS; Geoffrion R; Saboia DM; Bezerra KC; Vasconcelos Neto JA
    Neurourol Urodyn; 2020 Nov; 39(8):2344-2352. PubMed ID: 32846016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
    Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
    Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.